Marc Steven Hanover - Net Worth and Insider Trading
Marc Steven Hanover Net Worth
The estimated net worth of Marc Steven Hanover is at least $624 dollars as of 2025-04-26. Marc Steven Hanover is the CEO of Oncternal Therapeutics Inc and owns about 1,185 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $624. Details can be seen in Marc Steven Hanover's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marc Steven Hanover has not made any transactions after 2018-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marc Steven Hanover
Marc Steven Hanover Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marc Steven Hanover owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Marc Steven Hanover’s form 4 insider trades.
Insider Ownership Summary of Marc Steven Hanover
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2018-01-05 | director & Interim CEO & President and COO |
Marc Steven Hanover Latest Holdings Summary
Marc Steven Hanover currently owns a total of 1 stock. Marc Steven Hanover owns 1,185 shares of Oncternal Therapeutics Inc (ONCT) as of January 5, 2018, with a value of $624.
Latest Holdings of Marc Steven Hanover
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2018-01-05 | 1,185 | 0.53 | 624 |
Holding Weightings of Marc Steven Hanover
Marc Steven Hanover Form 4 Trading Tracker
According to the SEC Form 4 filings, Marc Steven Hanover has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the sale of 52 shares on January 5, 2018, which brought Marc Steven Hanover around $82,811.
Insider Trading History of Marc Steven Hanover
- 1
Marc Steven Hanover Trading Performance
GuruFocus tracks the stock performance after each of Marc Steven Hanover's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marc Steven Hanover is 22.88%. GuruFocus also compares Marc Steven Hanover's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marc Steven Hanover within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Marc Steven Hanover's insider trading performs compared to the benchmark.
Performance of Marc Steven Hanover
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.33 | | | | | |
| Relative Return to S&P 500(%) | 17.01 | | | | | |
Marc Steven Hanover Ownership Network
Ownership Network List of Marc Steven Hanover
Ownership Network Relation of Marc Steven Hanover
Marc Steven Hanover Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Marc Steven Hanover is the director & Interim CEO & President and COO of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Marc Steven Hanover made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 10,980 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Marc Steven Hanover Mailing Address
Above is the net worth, insider trading, and ownership report for Marc Steven Hanover. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Marc Steven Hanover's mailing address is: Memphis Tn 38103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
